Sponsor

Intarcia Therapeutics

Clinical research sponsor

Published trials15
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

15 shown
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on MetforminNCT03060980 · lead sponsor · 2017-03-03
TERMINATED
Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving LiraglutideNCT02638805 · lead sponsor · 2015-12-01
COMPLETED
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1cNCT01785771 · lead sponsor · 2013-05-01
TERMINATED
A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 DiabetesNCT01455870 · lead sponsor · 2013-05-01
COMPLETED
A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650NCT01455896 · lead sponsor · 2013-03-01
COMPLETED
A Study to Evaluate ITCA 650 for the Treatment of Type 2 DiabetesNCT01455857 · lead sponsor · 2013-03-01
COMPLETED
A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 DiabetesNCT01455883 · lead sponsor · 2013-02-01
WITHDRAWN
A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 DiabetesNCT01455922 · lead sponsor · 2013-02-01
WITHDRAWN
A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 DiabetesNCT01455909 · lead sponsor · 2013-02-01
WITHDRAWN
Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes MellitusNCT00943917 · lead sponsor · 2009-08-01
COMPLETED
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 DiabetesNCT01798264 · lead sponsor · 2009-02-01
COMPLETED
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast CancerNCT00267553 · lead sponsor · 2005-11-01
TERMINATED
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerNCT00097344 · lead sponsor · 2004-12-01
TERMINATED
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerNCT00044291 · lead sponsor · 2002-06-01
COMPLETED
Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast CancerNCT00010322 · lead sponsor · 2000-10-01
TERMINATED

Sponsor roles

lead sponsor15

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.